Stevanato Group S.p.A. (STVN): Price and Financial Metrics
STVN Price/Volume Stats
| Current price | $26.47 | 52-week high | $29.67 |
| Prev. close | $26.59 | 52-week low | $13.71 |
| Day low | $25.89 | Volume | 227,562 |
| Day high | $26.64 | Avg. volume | 282,755 |
| 50-day MA | $26.36 | Dividend yield | N/A |
| 200-day MA | $20.32 | Market Cap | 7.82B |
STVN Stock Price Chart Interactive Chart >
STVN POWR Grades
- STVN scores best on the Sentiment dimension, with a Sentiment rank ahead of 73.57% of US stocks.
- STVN's strongest trending metric is Growth; it's been moving up over the last 179 days.
- STVN ranks lowest in Momentum; there it ranks in the 6th percentile.
STVN Stock Summary
- STVN's went public 1.86 years ago, making it older than merely 4.81% of listed US stocks we're tracking.
- With a price/earnings ratio of 50.51, STEVANATO GROUP SPA P/E ratio is greater than that of about 88.54% of stocks in our set with positive earnings.
- The price/operating cash flow metric for STEVANATO GROUP SPA is higher than 93.57% of stocks in our set with a positive cash flow.
- If you're looking for stocks that are quantitatively similar to STEVANATO GROUP SPA, a group of peers worth examining would be HUDI, EMN, FMC, KTCC, and BIO.
- To dig deeper into the stock's financial statements, go to STVN's page on browse-edgar?action=getcompany&CIK=0001849853.
Stevanato Group S.p.A. (STVN) Company Bio
Stevanato Group S.p.A. engages in the design, production, and distribution of products and systems to provide integrated solutions for pharma and healthcare. Its principal products are linked to containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machine. Stevanato Group S.p.A. was founded in 1949 and is based in Piombino Dese, Italy.
Latest STVN News From Around the Web
Below are the latest news stories about STEVANATO GROUP SPA that investors may wish to consider to help them evaluate STVN as an investment opportunity.
Stevanato Group S.p.A. (NYSE:STVN) Released Earnings Last Week And Analysts Lifted Their Price Target To US$31.50Stevanato Group S.p.A. ( NYSE:STVN ) came out with its first-quarter results last week, and we wanted to see how the... |
As Covid Wanes, Maker Of Glass Vials, Other Medical Products Misses EstimatesGrowth stock Stevanato plunged after first quarter earnings as sales from Covid related services fell; maintained its full year outlook |
Stevanato Group (STVN) Q1 Earnings Lag EstimatesStevanato (STVN) delivered earnings and revenue surprises of -7.69% and 1.80%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock? |
Stevanato Group Reports First Quarter 2023 Financial ResultsPIOMBINO DESE, Italy, May 04, 2023--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, today announced its financial results for the first quarter of 2023, and maintained its fiscal 2023 guidance. |
Stevanato Group to Present at BofA Securities Healthcare ConferencePIOMBINO DESE, Italy, May 02, 2023--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today that it will participate in the upcoming BofA Securities Healthcare Conference at the Encore hotel in Las Vegas that will take place from May 9, 2023 to May 11, 2023. |
STVN Price Returns
| 1-mo | -3.04% |
| 3-mo | 11.64% |
| 6-mo | 65.44% |
| 1-year | 63.90% |
| 3-year | N/A |
| 5-year | N/A |
| YTD | 47.30% |
| 2022 | -19.96% |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
| 2018 | N/A |
Loading social stream, please wait...